MTAP and urothelial carcinoma: <b>Results</b>: MTAP deletion was detected in 14 cases (2.4%, 95% confidence interval [CI], 1.45-4.02%), with enrichment in sarcoma, pancreatic cancer, and urothelial carcinoma.